Metraipolis › archive › dc_7ca012dd0ae6

Non-clinical safety considerations on genome editing using the CRISPR/Cas system — Europe PMC PMID:41362674

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41362674
DOI
10.1016/j.gendis.2025.101785
License (as archived)
solo-consultazione
Archived
2026-10-08T02:35:05.391Z
SHA-256 of the archived text
aa6a46a7083590947cfd8616a05de974f96a7ac76d815e4548a71a6127046e40
Stable URL of this page
https://metraipolis.com/documento/dc_7ca012dd0ae6

How to cite

Non-clinical safety considerations on genome editing using the CRISPR/Cas system — Europe PMC PMID:41362674 — Europe PMC (en), https://europepmc.org/article/MED/41362674 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ca012dd0ae6 (Metraipolis archive dc_7ca012dd0ae6, sha256 aa6a46a7083590947cfd8616a05de974f96a7ac76d815e4548a71a6127046e40)
BibTeX
@misc{dc7ca012dd0ae6,
  title = {Non-clinical safety considerations on genome editing using the CRISPR/Cas system — Europe PMC PMID:41362674},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41362674},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ca012dd0ae6; sha256 aa6a46a7083590947cfd8616a05de974f96a7ac76d815e4548a71a6127046e40},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41362674. Agents can read the archived copy with the MCP tool read_document.